TGTX Stock Analysis: Buy, Sell, or Hold?
TGTX - TG Therapeutics, Inc.
$40.79
-1.86 (-4.36%)
▼
5d:
-5.19%
30d:
+17.89%
90d:
+43.53%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
TGTX is down 5.2% this week, but smart money is accumulating calls. Top strike: $50 2026-06-18 with 1,801 OI. Call ratio: 97% View Scanner →
Strength: 7.3/10
Get Alerted When TGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
12 traders called TGTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TGTX is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: TGTX is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$81.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$50.47
19.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TGTX is currently trading at $40.79, which is considered extended relative to its 30-day fair value range of $33.40 to $40.23. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (15.3). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TGTX is in a strong uptrend. Immediate support is located at $33.23, while resistance sits at $44.65. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: TGTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.14 (+12.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TGTX is in a strong uptrend. Immediate support is located at $33.23, while resistance sits at $44.65. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: TGTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.14 (+12.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$33.40 -
$40.23
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
Protect Your Profits
Holding TGTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading below Wall St target ($48.14)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
- CAUTION: 5-day price weakness (-5.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$33.40 -
$40.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$33.23
Resistance Level
$44.65
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.63
Wall Street Target
$48.14
(+12.9%)
Revenue Growth (YoY)
69.6%
Earnings Growth (YoY)
300.0%
Profit Margin
66.0%
Valuation Premium vs History
+0.6% premium
PE vs Historical
15.6 vs 15.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$42.91
(+1%)
2-Year Target
$43.16
(+1%)
3-Year Target
$43.42
(+2%)
3-Yr Target (if PE normalizes)
(PE: 16→15)
PE COMPRESSION
$42.50
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 69.1%)
$202.94
(+376%)
Base:
(SPY PE: 15.6, Growth: 69.1%)
$143.94
(+238%)
Bear:
(PE: 13.3, Growth: 69.1%)
$122.35
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 15.08 | Current EPS (TTM): $2.86
Bull Case
$45.27
(+6%)
Analyst growth -4.6%, PE expands to 16.6
Base Case
$41.15
(-4%)
Market implied -4.6%, PE stable at 15.1
Bear Case
$29.34
(-31%)
Severe decline -20.0%, PE contracts to 12.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Yann Echelard
SELL
5000 shares
2025-11-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$550 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 60 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 51 HOLD |
Advanced TGTX Option Strategies
Professional options setups generated by AI based on today's TGTX price and gamma walls.
